Caltrate 600 with Iron and Vitamin D Interactions
There are 313 drugs known to interact with Caltrate 600 with Iron and Vitamin D (calcium / ferrous fumarate / vitamin d), along with 13 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 24 are major, 243 are moderate, and 46 are minor.
- View all 313 medications that may interact with Caltrate 600 with Iron and Vitamin D
- View Caltrate 600 with Iron and Vitamin D alcohol/food interactions (3)
- View Caltrate 600 with Iron and Vitamin D disease interactions (13)
Most frequently checked interactions
View interaction reports for Caltrate 600 with Iron and Vitamin D (calcium / ferrous fumarate / vitamin d) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atenolol
- atorvastatin
- Centrum Silver (multivitamin with minerals)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- folic acid
- furosemide
- gabapentin
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- Nexium (esomeprazole)
- omeprazole
- Plavix (clopidogrel)
- prednisone
- ProAir HFA (albuterol)
- simvastatin
- Synthroid (levothyroxine)
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Caltrate 600 with Iron and Vitamin D alcohol/food interactions
There are 3 alcohol/food interactions with Caltrate 600 with Iron and Vitamin D (calcium / ferrous fumarate / vitamin d).
Caltrate 600 with Iron and Vitamin D disease interactions
There are 13 disease interactions with Caltrate 600 with Iron and Vitamin D (calcium / ferrous fumarate / vitamin d) which include:
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- hemoglobin abnormalities
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- achlorhydria
- gastrointestinal irritation
- hepatobiliary dysfunction
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.